Get the Stockscreener App
0.27
5.92%
0.0151
After Hours:
.34
0.07
+25.93%
Bioaffinity Technologies Inc stock is traded at $0.27, with a volume of 21.21M.
It is up +5.92% in the last 24 hours and down -1.42% over the past month.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
See More
Previous Close:
$0.2549
Open:
$0.2411
24h Volume:
21.21M
Relative Volume:
4.75
Market Cap:
$7.69M
Revenue:
$9.37M
Net Income/Loss:
$-8.45M
P/E Ratio:
-0.3333
EPS:
-0.81
Net Cash Flow:
$-7.27M
1W Performance:
+12.97%
1M Performance:
-1.42%
6M Performance:
-34.27%
1Y Performance:
-83.64%
1-Day Range:
$0.2402
$0.2799
1-Week Range:
$0.2355
$0.2799
52-Week Range:
$0.1639
$2.2592
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.27 | 7.55M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
bioAffinity Technologies Prepares for H.C. Wainwright Conference - MSN
bioAffinity Technologies Unveils New CyPath® Lung Case Study - TipRanks
Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass P - PharmiWeb.com
BioAffinity Technologies, Inc. Releases Another Completes a Completion of CyPath®? Lung, Identifies Cancer in a Patient with an Intention of Ground-Glass Lung Nodules - MarketScreener
bioAffinity Technologies Inc. Forms Bullish Flag — Upside AheadJuly 2025 Recap & Risk Adjusted Buy/Sell Alerts - beatles.ru
bioAffinity’s CyPath® Lung Test Detects Early Cancer - MSN
Evaluating bioAffinity Technologies Inc. with trendline analysis2025 Risk Factors & Daily Profit Maximizing Tips - Newser
Published on: 2025-09-06 13:22:00 - Newser
Why is bioAffinity Technologies Inc. Equity Warrant stock going down2025 Sector Review & Daily Momentum Trading Reports - خودرو بانک
A | Is bioAffinity Technologies, Inc. stock a value trapJobs Report & Advanced Technical Analysis Signals - خودرو بانک
How high can bioAffinity Technologies Inc. Equity Warrant stock goPortfolio Risk Summary & Real-Time Volume Trigger Notifications - Newser
RSI Suggests Rebound May Be Near in bioAffinity Technologies Inc. Equity WarrantPortfolio Profit Report & Risk Managed Trade Strategies - beatles.ru
How to forecast bioAffinity Technologies Inc. trends using time seriesJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - Newser
Can bioAffinity Technologies Inc. be recession proofJuly 2025 News Drivers & Weekly Sector Rotation Insights - خودرو بانک
Will bioAffinity Technologies Inc. Equity Warrant outperform during market rallies2025 Top Gainers & Safe Entry Trade Reports - خودرو بانک
Risk vs reward if holding onto bioAffinity Technologies Inc. Equity Warrant2025 Price Momentum & AI Enhanced Trading Signals - Newser
What MACD signals say about bioAffinity Technologies Inc. Equity WarrantPortfolio Return Summary & Real-Time Buy Signal Alerts - Newser
What’s next for bioAffinity Technologies Inc. stock priceEarnings Overview Summary & Weekly Top Stock Performers List - Newser
What to expect from bioAffinity Technologies Inc. in the next 30 daysPortfolio Gains Summary & Risk Managed Investment Entry Signals - Newser
Predicting bioAffinity Technologies Inc. trend using moving averagesJuly 2025 Gainers & Long-Term Safe Investment Ideas - Newser
bioAffinity Technologies Inc. stock daily chart insightsJuly 2025 Recap & Expert Approved Momentum Trade Ideas - Newser
What dividend growth rate does bioAffinity Technologies Inc. offer2025 Technical Overview & Daily Momentum Trading Reports - خودرو بانک
Can bioAffinity Technologies Inc. Equity Warrant outperform under higher oil pricesGDP Growth & Safe Swing Trade Setups - خودرو بانک
Sentiment analysis tools applied to bioAffinity Technologies Inc. Equity Warrant2025 Pullback Review & Reliable Price Breakout Alerts - Newser
Using Ichimoku Cloud for bioAffinity Technologies Inc. Equity Warrant technicals2025 Support & Resistance & Verified Short-Term Trading Plans - Newser
Published on: 2025-09-04 22:34:10 - Newser
Is bioAffinity Technologies Inc. Equity Warrant benefiting from interest rate changes2025 Trade Ideas & Safe Capital Growth Plans - خودرو بانک
Can machine learning forecast bioAffinity Technologies Inc. recoveryWeekly Risk Summary & Free Expert Approved Momentum Trade Ideas - Newser
Best data tools to analyze bioAffinity Technologies Inc. Equity Warrant stockLong Setup & Safe Capital Growth Stock Tips - Newser
Is bioAffinity Technologies Inc. Equity Warrant a candidate for recovery playTake Profit & Reliable Price Action Trade Plans - Newser
How to monitor bioAffinity Technologies Inc. with trend dashboardsWeekly Volume Report & Growth Focused Investment Plans - Newser
Can bioAffinity Technologies Inc. stock double in the next yearAnalyst Downgrade & Free Fast Gain Swing Trade Alerts - خودرو بانک
What data driven models say about bioAffinity Technologies Inc. Equity Warrant’s futurePortfolio Profit Report & AI Based Buy/Sell Signal Reports - Newser
Will bioAffinity Technologies Inc. Equity Warrant price bounce be sustainableRate Cut & Low Drawdown Trading Techniques - Newser
Detecting price anomalies in bioAffinity Technologies Inc. with AI2025 Stock Rankings & Daily Stock Momentum Reports - Newser
Using fundamentals and technicals on bioAffinity Technologies Inc. Equity WarrantPortfolio Return Report & Low Drawdown Trading Techniques - Newser
Using economic indicators to assess bioAffinity Technologies Inc. Equity Warrant potentialQuarterly Growth Report & Weekly Top Performers Watchlists - Newser
Can a trend reversal in bioAffinity Technologies Inc. Equity Warrant lead to recovery2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - Newser
Candlestick signals on bioAffinity Technologies Inc. Equity Warrant stock todayMarket Risk Report & Consistent Income Trade Recommendations - Newser
Real time social sentiment graph for bioAffinity Technologies Inc. Equity WarrantSwing Trade & Weekly Top Performers Watchlists - Newser
Regression analysis insights on bioAffinity Technologies Inc. Equity Warrant performanceEarnings Beat & Verified High Yield Trade Plans - Newser
Using R and stats models for bioAffinity Technologies Inc. forecastingMarket Activity Recap & Accurate Intraday Trading Signals - Newser
bioAffinity Technologies’ CyPath® Lung Test Featured in U.S. Medicine - TipRanks
Is bioAffinity Technologies Inc. exposed to political risk2025 Investor Takeaways & Low Volatility Stock Suggestions - خودرو بانک
Published on: 2025-09-03 07:00:43 - Newser
$895M Healthcare Savings: Revolutionary CyPath Lung Test Achieves 92% Accuracy in Early Cancer Detection - Stock Titan
What machine learning models say about bioAffinity Technologies Inc. Equity WarrantTrade Signal Summary & Real-Time Stock Price Movement Reports - Newser
Is bioAffinity Technologies Inc. Equity Warrant’s ROE strong enoughWeekly Trade Review & Expert Curated Trade Setups - خودرو بانک
Historical volatility pattern of bioAffinity Technologies Inc. visualizedWeekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser
Comparing bioAffinity Technologies Inc. in custom built stock radarsMarket Activity Summary & Smart Allocation Stock Tips - Newser
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):